A critical review on health promoting benefits of edible mushrooms through gut microbiota

International Journal of Molecular Sciences

Volumn 18, Issue 9, 2017, Pages

  Jayachandran, Muthukumaran ^a   Xiao, Jianbo ^b   Xu, Baojun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b University of Macau   (Macao)

Author keywords

Anti cancer; Anti diabetic; Gut microbiota; Mushroom; Prebiotics

Indexed keywords

ASCORBIC ACID; CARBOHYDRATE; CATECHOLAMINE; CHITIN; GALACTAN; GLUCAN; HEMICELLULOSE; MANNAN; NICOTINIC ACID; PREBIOTIC AGENT; PYRIDOXINE; RIBOFLAVIN; THIAMINE; XYLAN;

ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CELL MIGRATION; CITROBACTER RODENTIUM; EDIBLE MUSHROOM; G1 PHASE CELL CYCLE CHECKPOINT; GANODERMA; GRIFOLA FRONDOSA; HEALTH BEHAVIOR; HERICIUM ERINACEUS; HUMAN; HYPERGLYCEMIA; INONOTUS OBLIQUUS; INTESTINE FLORA; LIVER PROTECTION; MICROBIOME; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHELLINUS LINTEUS; REVIEW; TRAMETES VERSICOLOR; AGARICALES; ANIMAL; CHEMISTRY; CLASSIFICATION; ENERGY METABOLISM; HEALTH PROMOTION; IMMUNOMODULATION; TRADITIONAL MEDICINE;

AGARICALES; ANIMALS; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; HEALTH PROMOTION; HUMANS; IMMUNOMODULATION; MEDICINE, TRADITIONAL; PREBIOTICS;

EID: 85029179318     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18091934     Document Type: Review

References (71)

1. Rathee, S.; Rathee, D.; Rathee, D.; Kumar, V.; Rathee, P. Mushrooms as therapeutic agents. Rev. Bras. Farmacogn. 2012, 22, 457–474.
2. Abugri, D.; McElhenney, W.H.; Willian, K.R. Fatty acid profiling in selected cultivated edible and wild medicinal mushrooms in the Southern United States. J. Exp. Food Chem. 2016, 2, 1–7.
3. Mhanda, F.N.; Kadhila-Muandingi, N.P.; Ueitele, I.S.E. Minerals and trace elements in domesticated Namibian Ganoderma species. Afr. J. Biotechnol. 2015, 14, 3216–3218.
4. De Sousa, V.M.C.; Dos Santos, E.F.; Sgarbieri, V.C. The importance of prebiotics in functional foods and clinical practice. Food Nutr. Sci. 2011, 2, 4.
5. Bhakta, M.; Kumar, P. Mushroom polysaccharides as a potential prebiotics. Int. J. Health Sci. Res. 2013, 3, 77–84.
6. Cani, P.D.; Delzenne, N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009, 15, 1546–1558.
7. Petrovska, B. Protein fraction of edible Macedonian mushrooms. Eur. Food Sci. Technol. 2001, 212, 469–472.
8. Batbayar, S.; Lee, D.H.; Kim, H.W. Immunomodulation of fungal β-glucan in host defense signaling by dectin-1. Biomol. Ther. 2012, 20, 433–445.
9. 2 content following UV-C irradiation. Int. J. Vitam. Nutr. Res. 2016, 21, 1–10.
10. Robbins, R.J. Phenolic acids in foods: An overview of analytical methodology. J. Agric. Food Chem. 2003, 51, 2866–2887.
11. Islam, T.; Yu, X.; Xu, B. Phenolic profiles, antioxidant capacities and metal chelating ability of edible mushroom commonly consumed in China. LWT Food Sci. Technol. 2016, 72, 423–431.
12. Rai, M.; Tidke, G.; Wasser, S.P. Therapeutic potential of mushrooms. Nat. Prod. Radiance 2005, 4, 246–257.
13. Nahata, A. Ganoderma lucidum: A potent medicinal mushroom with numerous health benefits. Pharm. Anal. Acta 2013, 4, 10.
14. Smina, T.P.; Nitha, B.; Devasagayam, T.P.; Janardhanan, K.K. Ganoderma lucidum total triterpenes induce apoptosis in MCF-7 cells and attenuate DMBA induced mammary and skin carcinomas in experimental animals. Mutat. Res. 2017, 813, 45–51.
15. Zeng, Q.; Zhou, F.; Lei, L.; Chen, J.; Lu, J.; Zhou, J.; Cao, K.; Gao, L.; Xia, F.; Ding, S. et al. Ganoderma lucidumpolysaccharides protect fibroblasts against UVB-induced photoaging. Mol. Med. Rep. 2016, 15, 111–116.
16. Wu, Y.S.; Ho, S.Y.; Nan, F.H. Ganoderma lucidum β 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet. BMC Complement. Altern. Med. 2016, 16, 500.
17. Shuhaimi, Y.S.; Arbakariya, M.; Fatimah, A.; Khalilah, A.B.; Anas, A.K.; Yazid, A.M. Effect of Ganoderma lucidumpolysaccharides on the growth of Bifidobacterium spp. as assessed using Real-time PCR. Int. Food Res. J. 2012, 19, 1199–1205.
18. Li, K.; Zhuo, C.; Teng, C.; Yua, S.; Wang, X.; Hu, Y.; Ren, G.; Yu, M.; Qu, J. Effects of Ganoderma lucidumpolysaccharides on chronic pancreatitis and intestinal microbiota in mice. Int. J. Biol. Macromol. 2016, 93, 904–912.
19. Tang, X.; Cai, W.; Xu, B. Comparison of the chemical profiles and antioxidant and antidiabetic activities of extracts from two Ganoderma species (Agaricomycetes). Int. J. Med. Mushrooms 2016, 18, 609–620.
20. Wang, X.L.; Ding, Z.Y.; Liu, G.Q. Improved production and antitumor properties of triterpene acids from submerged culture of Ganoderma lingzhi. Molecules 2016, 21, 1395.
21. Wu, H.; Tang, S.Z.; Huang, Q. Hepatoprotective effects and mechanisms of action of triterpenoids from lingzhi or reishi medicinal mushroom Ganoderma lucidum (Agaricomycetes) on α-amanitin-induced liver injury in mice. Int. J. Med. Mushrooms 2016, 18, 841–850.
22. Rajasekaran, M.; Kalaimagal, C. In vitro antioxidant activity of ethanolic extract of a medicinal mushroom, Ganoderma lucidum. J. Pharm. Sci. Res. 2011, 3, 1427–1433.
23. Spinosa, R. The chaga storey. Mycophile 2006, 47, 1–8.
24. Hartwell, J.L. Plants Used against Cancer; Quartermain Publishing: Lawrence, MA, USA, 1982; 694p.
25. Hong, K.B.; Noh, D.O.; Park, Y.; Suh, H.J. Hepatoprotective activity of water extracts from chaga medicinal mushroom, Inonotus obliquus (higher Basidiomycetes) against tert-butyl hydroperoxide induced oxidative liver injury in primary cultured rat hepatocytes. Int. J. Med. Mushrooms 2015, 17, 1069–1076.
26. Kang, J.H.; Jang, J.E.; Mishra, S.K.; Lee, H.J.; Nho, C.W.; Shin, D.; Jin, M.; Kim, M.K.; Choi, C.; Oh, S.H. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer. J. Ethnopharmacol. 2015, 15, 303–312.
27. Lee, H.S.; Kim, E.J.; Kim, S.H. Ethanol extract of Innotus obliquus (chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells. Nutr. Res. Pract. 2015, 9, 111–116.
28. Hu, Y.; Teng, C.; Yu, S.; Wang, X.; Liang, J.; Bai, X.; Dong, L.; Song, T.; Yu, M.; Qu, J. Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice. AMB Express 2017, 7, 39.
29. Luo, K.W.; Yue, G.G.; Ko, C.H.; Lee, J.K.; Gao, S.; Li, L.F.; Li, G.; Fung, K.P.; Leung, P.C.; Lau, C.B. In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine 2014, 21, 1078–1087.
30. Kobayashi, M.; Kawashima, H.; Takemori, K.; Ito, H.; Murai, A.; Masuda, S.; Yamada, K.; Uemura, D.; Horio, F. Ternatin, a cyclic peptide isolated from mushroom, and its derivative suppress hyperglycemia and hepatic fatty acid synthesis in spontaneously diabetic KK-A(y) mice. Biochem. Biophys. Res. Commun. 2012, 427, 299–304.
31. Yu, Z.T.; Liu, B.; Mukherjee, P.; Newburg, D.S. Trametes versicolor extract modifies human fecal microbiota composition in vitro. Plant Foods Hum. Nutr. 2013, 68, 107–112.
32. Pallav, K.; Dowd, S.E.; Villafuerte, J.; Yang, X.; Kabbani, T.; Hansen, J.; Dennis, M.; Leffler, D.A.; Newburg, D.S.; Kelly, C.P. Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers. Gut Microbes 2014, 5, 458–467.
33. Matijašević, D.; Pantić, M.; Rašković, B.; Pavlović, V.; Duvnjak, D.; Sknepnek, A.; Nikšić, M. The antibacterial activity of Coriolus versicolor methanol extract and its effect on ultrastructural changes of Staphylococcus aureus and Salmonella Enteritidis. Front. Microbiol. 2016, 7, 1226.
34. Alonso, E.N.; Ferronato, M.J.; Gandini, N.A.; Fermento, M.E.; Obiol, D.J.; Lopez Romero, A.; Arévalo, J.; Villegas, M.E.; Facchinetti, M.M.; Curino, A.C. Antitumoral effects of D-fraction from Grifola frondosa (maitake) mushroom in breast cancer. Nutr. Cancer 2017, 69, 29–43.
35. Lin, C.H.; Chang, C.Y.; Lee, K.R. Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo. Exp. Biol. Med. 2016, 241, 1374–1385.
36. Harhaji, L.J.; Mijatović, S.; Maksimović-Ivanić, D.; Stojanović, I.; Momcilović, M.; Maksimović, V.; Tufegdzić, S.; Marjanović, Z.; Mostarica-Stojković, M.; Vucinić, Z. et al. Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: In vitro and in vivo study. Food Chem. Toxicol. 2008, 46, 1825–1833.
37. Phillip, A.; Green, E.S.J.; Voigt, R.M. The gastrointestinal microbiome alcohol effects on the composition of intestinal microbiota. Alcohol. Res. 2015, 37, 223–236.
38. Guinane, C.M.; Cotter, P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Ther. Adv. Gastroenterol. 2013, 6, 295–308.
39. Conlon, M.A.; Bird, A.R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2014, 7, 17–44.
40. Houghton, D.; Stewart, C.J.; Christopher, P. Gut microbiota and lifestyle interventions in NAFLD. Int. J. Mol. Sci.2016, 17, 447.
41. Clarke, S.F.; Murphy, E.F.; Nilaweera, K. The gut microbiota and its relationship to diet and obesity new insights. Gut Microbes 2012, 3, 186–202.
42. Finelli, C.; Tarantino, G. Non-alcoholic fatty liver disease, diet and gut microbiota. EXCLI J. 2014, 13, 461–490.
43. Schuijt, T.J.; Lankelma, J.M.; Scicluna, B.P.; Schuijt, T.J.; Lankelma, J.M.; Scicluna, B.P.; de Sousa e Melo, F.; Roelofs, J.J.; de Boer, J.D.; Hoogendijk, A.J. et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016, 65, 575–583.
44. Vyas, U.; Ranganathan, N. Probiotics, prebiotics, and synbiotics: Gut and beyond. Gastroenterol. Res. Pract. 2012, 872716.
45. Jandhyala, S.M.; Talukdar, R.; Subramanyam, C.; Vuyyuru, H.; Sasikala, M.; Reddy, D.N. Role of the normal gut microbiota. World J. Gastroenterol. 2015, 21, 8787–8803.
46. Le Blanc, J.G.; Milani, C.; de Giori, G.S. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr. Opin. Biotechnol. 2013, 24, 160–168.
47. Kang, M.J.; Kim, H.G.; Kim, J.S.; Oh, D.G.; Um, Y.J.; Seo, C.S.; Han, J.W.; Cho, H.J.; Kim, G.H.; Jeong, T.C. et al. The effect of gut microbiota on drug metabolism. Expert Opin. Drug Metab. Toxicol. 2013, 9, 1295–1308.
48. Wu, H.J.; Wu, E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012, 3, 4–14.
49. Okumura, R.; Takeda, K. Maintenance of gut homeostasis by the mucosal immune system. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2016, 92, 423–435.
50. Goto, Y.; Ivanov, I.I. Intestinal epithelial cells as mediators of the commensal–host immune crosstalk. Immunol. Cell Biol. 2013, 91, 204–214.
51. Hutkins, R.W.; Krumbeck, J.A.; Bindels, L.B.; Cani, P.D.; Fahey, G., Jr.; Goh, Y.J.; Hamaker, B.; Martens, E.C.; Mills, D.A.; Rastal, R.A. et al. Prebiotics: Why definitions matter. Curr. Opin. Biotechnol. 2016, 37, 1–7.
52. Singdevsachan, S.K.; Mishra, P.A.J.; Baliyarsingh, B.; Tayung, K.; Thatoi, H. Mushroom polysaccharides as potential prebiotics with their antitumor and immunomodulating properties: A review. Bioact. Carbohydr. Diet. Fibre 2015, 7, 1–14.
53. Varshney, J.; Ooi, J.H.; Jayarao, B.M. White button mushrooms increase microbial diversity and accelerate the resolution of Citrobacterrodentium infection in mice. J. Nutr. 2013, 143, 526–532.
54. Meneses, M.E.; Carrera, M.D.; Torres, N. Hypocholesterolemic properties and prebiotic effects of Mexican Ganoderma lucidum in C57BL/6 Mice. PLoS ONE 2016, 11, e0159631.
55. Giannenasa, I.; Tsalie, E.B.; Chronisc, E.F. Consumption of Agaricus bisporus mushroom affects the performance, intestinal microbiota composition and morphology, and antioxidant status of turkey poults. Anim. Feed Sci. Technol.2011, 165, 218–229.
56. Geurts, L.; Neyrinck, A.M.; Delzenne, N.M. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics. Benef. Microbes 2014, 5, 3–17.
57. Xu, X.; Zhang, X. Lentinula edodes-derived polysaccharide alters the spatial structure of gut microbiota in mice. PLoS ONE 2015, 10, e0115037.
58. Saman, P.; Chaiongkarn, A.; Moonmangmee, S.; Sukcharoen, J.; Kuancha, C.; Fungsin, B. Evaluation of prebiotic property in edible mushrooms. Biol. Chem. Res. 2016, 3, 75–85.
59. Pandeya, D.R.; Souza, R.D.; Rahman, M.M. Host-microbial interaction in the mammalian intestine and their metabolic role inside. Biomed. Res. 2011, 2, 1–8.
60. Gerritsen, J.; Smidt, H.; Rijkers, G.T.; de Vos, W.M. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr. 2011, 6, 209–240.
61. Khoruts, A.; Dicksved, J.; Jansson, J.K.; Sadowsky, M.J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 2010, 44, 354–360.
62. Hetland, G.; Dag, M.; Eide, M.; Haugen, M.H.; Mirlashari, M.R.; Paulsen, J.E. The Agaricus blazei-based mushroom extract, andosan, protects against intestinal tumorigenesis in the A/J Min/+ mouse. PLoS ONE 2016, 11, e0167754.
63. Huang, H.Y.; Korivi, M.; Chaing, Y.Y.; Chien, T.Y.; Tsai, Y.C. Pleurotus tuber-regium polysaccharides attenuate hyperglycemia and oxidative stress in experimental diabetic rats. J. Evid. Based Complement. Altern. Med. 2012, 856381.
64. Chang, C.J.; Lin, C.S.; Lu, C.C.; Martel, J.; Ko, Y.F.; Ojcius, D.M.; Tseng, S.F.; Wu, T.R.; Chen, Y.Y.; Young, J.D. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun. 2015, 6, 7489.
65. Stamets, P.E. Integrative Fungal Solutions for Protecting Bees and Overcoming Colony Collapse Disorder (CCD): Methods and Compositions. U.S. Patent 20140220150 A1, 7 August 2014.
66. Kim, H.; Han, S.; Lee, C.; Lee, K.; Hong, D. Compositions Containing Polysaccharides from Phellinus linteus and Methods for Treating Diabetes Mellitus Using Same. U.S. Patent 6,809,084 B1, 26 October 2004.
67. Kuo, H.C.; Lu, C.C.; Shen, C.H.; Tung, S.Y.; Hsieh, M.C.; Lee, K.C.; Lee, L.Y.; Chen, C.C.; Teng, C.C.; Huang, W.S. et al. Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. J. Transl. Med. 2016, 14, 78.
68. Lindequist, U.; Niedermeyer, T.H.J.; Julich, W.D. The pharmacological potential of mushrooms. Evid. Based Complement. Altern. Med. 2005, 2, 285–299.
69. Xu, X.; Yang, J.; Ning, Z. Lentinula edodes-derived polysaccharide rejuvenates mice in terms of immune responses and gut microbiota. Food Funct. 2015, 6, 2653–2663.
70. Grienke, U.; Zoll, M.; Peintner, U. European medicinal polypores—A modern view on traditional uses. J. Ethnopharmacol. 2014, 154, 564–583.
71. Lemieszek, M.; Rzeski, W. Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemp. Oncol. 2012, 16, 285–289.